Peter George, CEO, Clinigen Group, said: ‘In obtaining both SAVENE and Cardioxane, Clinigen shall expand its strategic choices in oncology support and consolidate its source chain. The acquisition was a natural move for us and is in line with our stated technique to increase our specialty pharmaceuticals portfolio.’ David Bryant, Senior Vice President, Clinigen SP, said: ‘This is actually the fourth item to be put into our specialty pharmaceuticals portfolio. We continue to focus on the acquisition of market, hospital-only therapies that have the potential to save the entire lives of critically ill patients.’.. CMS awards $306M to states for enrolling even more kids in Medicaid The Centers For Medicare & Medicaid Providers on Wednesday awarded $306 million in bonuses to 23 states for enrolling more children in Medicaid.As a total result, the figures of previous periods might present variations in relation to the figures already published. Related StoriesAddressing standard of living needs in prostate tumor: an interview with Professor Louis DenisGenetic carrier screening: an interview with Don Hardison, CEO of Good Begin GeneticsOJ Bio at Medica 2015 – Point of Treatment diagnostics' function in reducing antibiotics prescribingHIGHLIGHTS Total MEMBERSHIP stood at 5,820.of December 2011 5 thousand at the end, 9.6 percent up on the 4Q10 and 2.1 percent greater than in the 3Q11. Altered OPERATING REVENUES totaled R$ 2,521.1 million in the 4Q11, 22.5 percent up year-on-year and 6.8 percent more than the prior quarter. In 2011 working revenues amounted to R$ 9,274.6 million, 18.6 percent up on 2010.